Display options
Share it on

J Evol Stem Cell Res. 2017;1(2):1-11. doi: 10.14302/issn.2574-4372.jesr-16-1395. Epub 2017 Jan 24.

Calcium Transient Assays for Compound Screening with Human iPSC-derived Cardiomyocytes: Evaluating New Tools.

Journal of evolving stem cell research

Neil J Daily, Radleigh Santos, Joseph Vecchi, Pinar Kemanli, Tetsuro Wakatsuki

Affiliations

  1. InvivoSciences, Inc., Madison, WI.
  2. Torrey Pines Institute for Molecular Studies, Port St. Lucie, FL.

PMID: 28966998 PMCID: PMC5621642 DOI: 10.14302/issn.2574-4372.jesr-16-1395

Abstract

Calcium (Ca2+) plays a central role in regulating many biological processes in the cell from muscle contraction to neurotransmitter release. The need for reliable fluorescent calcium indicator dyes is of vast importance for studying many aspects of cell biology as well as screening compounds using phenotypic high throughput assays. We have assessed two of the latest generation of calcium indicator dyes, FLIPR Calcium 6 and Cal-520 AM for studying calcium transients (CaTs) in induced pluripotent stem cell (iPSC) -derived human cardiomyocytes. FLIPR Calcium 6 and Cal-520 dyes both displayed robust CaTs with a high signal-to-noise ratio (SNR) and were non-toxic to the cells. The analysis showed that CaT amplitudes were stable between measurements, but CaT duration was more variable and tended to increase between reads. Two methods were compared for drug-screening hit-selection; difference in average (unstandardized) and standardized difference. The unstandardized difference was better for assessing CaT amplitude, whereas standardized difference was equal to or better for assessing CaT duration. In summary, FLIPR Calcium 6 and Cal-520 are suitable dyes for drug-screening using iPSC-derived human cardiomyocytes.

Conflict of interest statement

Conflict of interests Research projects were conducted at the laboratory of InvivoSciences, Inc. that is a for-profit company.

References

  1. J Biomol Screen. 2007 Aug;12(5):705-14 - PubMed
  2. Stem Cells. 2013 May;31(5):829-37 - PubMed
  3. Nat Rev Drug Discov. 2016 Jul;15(7):457-71 - PubMed
  4. J Biomol Screen. 2003 Oct;8(5):571-7 - PubMed
  5. Nature. 2002 Jan 10;415(6868):198-205 - PubMed
  6. Hypertension. 1992 Mar;19(3):228-36 - PubMed
  7. J Pharmacol Toxicol Methods. 2016 Sep-Oct;81:217-22 - PubMed
  8. Toxicol Pathol. 2006;34(1):81-90 - PubMed
  9. Methods Mol Biol. 2005;312:119-24 - PubMed
  10. Infect Control Hosp Epidemiol. 1997 Jan;18(1):65-73 - PubMed
  11. J Natl Cancer Inst. 2010 Jan 6;102(1):14-25 - PubMed
  12. Nat Rev Cardiol. 2013 Feb;10(2):85-97 - PubMed
  13. J Biol Chem. 1985 Mar 25;260(6):3440-50 - PubMed
  14. Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):E1848-57 - PubMed
  15. World J Stem Cells. 2015 Mar 26;7(2):329-42 - PubMed
  16. Cardiovasc Res. 2003 Apr 1;58(1):32-45 - PubMed
  17. J Biomol Screen. 2012 Jul;17(6):705-12 - PubMed
  18. Am J Physiol Heart Circ Physiol. 2016 Jul 1;311(1):H44-53 - PubMed

Publication Types

Grant support